Retraction
Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Breast Cancer
Paper Information
Record ID:
38756
Author(s):
Journal:
Publication Date:
April 06, 2019
Retraction Date:
May 23, 2022
(3.5 years years ago)
Subjects:
Broad Categories:
Biology
Biology
Institutions:
- Department of Occupational and Environmental Health, School of Health Sciences, Wuhan University, Wuhan 430071, Hubei, China
- Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: chengcaosun@whu.edu.cn
- Wuhan Hospital for the Prevention and Treatment of Occupational Diseases, Wuhan 430022, Hubei, China
- Department of Occupational and Environmental Health, School of Health Sciences, Wuhan University, Wuhan 430071, Hubei, China
- Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
- Department of Oncology, Wuhan Pu-Ai Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430034, Hubei, China
- Hubei Provincial Key Laboratory for Applied Toxicology, Hubei Provincial Academy for Preventive Medicine, Wuhan 430079, Hubei, China
- Department of Infectious Diseases, Wuhan Medical Treatment Center, Wuhan 430071, Hubei, China
- Department of Oncology, ZhongNan Hospital of Wuhan University, Wuhan 430071, Hubei, China
- Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang 441021, Hubei, China
- Department of Pathology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, Hubei, China
- Department of Occupational and Environmental Health, School of Health Sciences, Wuhan University, Wuhan 430071, Hubei, China. Electronic address: heqiqiang@gmail.com
- Department of Occupational and Environmental Health, School of Health Sciences, Wuhan University, Wuhan 430071, Hubei, China. Electronic address: lodjlwhu@sina.com
Countries:
Article Type:
Publisher:
Elsevier - Cell Press
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (140)
140
Total Citations59
Post-Retraction(42.1%)
81
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
39
Within 1 year
2
After 2+ years
1110
Days since retraction (latest)
Comprehensive analysis of GINS subunits prognostic value and ceRNA network in sarcoma
Chuqiao Zhou, Zhuoyuan Chen, Bo Xiao et al. (7 authors)
Frontiers in Cell and Developmental Biology
Open Access
Published: Aug 2022
7 citations
7 citations
95 days after retraction
RUNX regulated immune-associated genes predicts prognosis in breast cancer
Jingyue Fu, Handong Sun, Feng Xu et al. (7 authors)
Frontiers in Genetics
Open Access
Published: Aug 2022
6 citations
6 citations
95 days after retraction
Comprehensive bioinformatics analysis of the E2F family in human clear cell renal cell carcinoma
Zhiguo Liu, Jing Su, Hao Liu et al. (10 authors)
Oncology Letters
Open Access
Published: Aug 2022
7 citations
7 citations
88 days after retraction
The histone deacetylase SIRT6 promotes glycolysis through the HIF-1α/HK2 signaling axis and induces erlotinib resistance in non-small cell lung cancer
Qiai You, Jianmin Wang, Yongxin Yu et al. (11 authors)
APOPTOSIS
Open Access
Published: Aug 2022
16 citations
16 citations
70 days after retraction
Circ_0004676 exacerbates triple-negative breast cancer progression through regulation of the miR-377-3p/E2F6/PNO1 axis
Guoli Shao, Xulong Fan, Pusheng Zhang et al. (6 authors)
Cell Biology and Toxicology
Published: Jul 2022
11 citations
11 citations
61 days after retraction
E2F Transcription Factor 1 Activates FKBP Prolyl Isomerase 4 to Promote Angiogenesis in Cervical Squamous Cell Carcinoma Via the PI3K/AKT Signaling Pathway
Jiazhen Huang, Ying Zhao
Reproductive Sciences
Published: Jul 2022
8 citations
8 citations
56 days after retraction
E2F4 transcription factor is a prognostic biomarker related to immune infiltration of head and neck squamous cell carcinoma
Qi Li, Zihan Ren, Wei Li
Scientific Reports
Open Access
Published: Jul 2022
5 citations
5 citations
53 days after retraction
Comprehensive Analysis of ABCA Family Members in Lung Adenocarcinoma with Prognostic Values
Yanxia Yang, Xiaoping Liu, Xin Wang et al. (6 authors)
Molecular Biotechnology
Published: Jun 2022
4 citations
4 citations
35 days after retraction
Prognostic and tumor immunity implication of inflammatory bowel disease-associated genes in colorectal cancer
Di Wang, Biao Xie
European journal of medical research
Open Access
Published: Jun 2022
2 citations
2 citations
21 days after retraction
MicroRNA-144-3p Represses the Growth and EMT of Thyroid Cancer via the E2F2/TNIK Axis in Cells and Male BALB/c Nude Mice
Dan Yi, Dongxin Zhang, Zhaohui Zeng et al. (6 authors)
Endocrinology
Open Access
Published: May 2022
11 citations
11 citations
6 days before retraction
A Novel Five-Gene Signature Related to Clinical Outcome and Immune Microenvironment in Breast Cancer
Yi Yang, Hongli Liu, Yi‐Jing Liu
Frontiers in Genetics
Open Access
Published: May 2022
5 citations
5 citations
10 days before retraction
Transcription Factor E2F1 Exacerbates Papillary Thyroid Carcinoma Cell Growth and Invasion via Upregulation of LINC00152
Junjie Yang, Yong Ying, Xiangtai Zeng et al. (8 authors)
Analytical Cellular Pathology
Open Access
Published: May 2022
9 citations
9 citations
13 days before retraction
Cynometra cauliflora essential oils loaded-chitosan nanoparticles: Evaluations of their antioxidant, antimicrobial and cytotoxic activities
Benedict Samling, Zaini Assim, Woei Yenn Tong et al. (8 authors)
International Journal of Biological Macromolecules
Published: May 2022
28 citations
28 citations
21 days before retraction
Identification and validation of a novel prognostic signature based on transcription factors in breast cancer by bioinformatics analysis
Yingmei Yang, Zhaoyun Li, Qianyi Zhong et al. (6 authors)
Gland Surgery
Open Access
Published: May 2022
6 citations
6 citations
22 days before retraction
Systematic Analysis of E2F Expression and Its Relation in Colorectal Cancer Prognosis
ZhaoHui Xu, Hui Qu, YanYing Ren et al. (9 authors)
International Journal of General Medicine
Open Access
Published: May 2022
6 citations
6 citations
22 days before retraction
Differential Expression of E2F Transcription Factors and Their Functional and Prognostic Roles in Human Prostate Cancer
Zhaodong Han, Rujun Mo, Shanghua Cai et al. (15 authors)
Frontiers in Cell and Developmental Biology
Open Access
Published: Apr 2022
17 citations
17 citations
32 days before retraction
High Expression of Bloom Syndrome Helicase is a Key Factor for Poor Prognosis and Advanced Malignancy in Patients with Pancreatic Cancer: A Retrospective Study
Chuan Lan, Yo‐ichi Yamashita, Hiromitsu Hayashi et al. (13 authors)
Annals of Surgical Oncology
Published: Apr 2022
6 citations
6 citations
40 days before retraction
Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas
Cheng Wei, Bo Wang, Dazhao Peng et al. (14 authors)
Frontiers in Immunology
Open Access
Published: Apr 2022
84 citations
84 citations
49 days before retraction
Clinical Impact of 11q13.3 Amplification on Immune Cell Infiltration and Prognosis in Breast Cancer
Renyu Zhou, Xiaoxi Zhu, Yulong Peng et al. (9 authors)
International Journal of General Medicine
Open Access
Published: Apr 2022
12 citations
12 citations
52 days before retraction
Abnormal spindle-like microcephaly-associated protein promotes proliferation by regulating cell cycle in epithelial ovarian cancer
Yiguo Wu, Yujuan You, Ling Chen et al. (7 authors)
Gland Surgery
Open Access
Published: Apr 2022
8 citations
8 citations
52 days before retraction
An integrated analysis of prognostic and immune infiltrates for hub genes as potential survival indicators in patients with lung adenocarcinoma
Zhiyun Xu, Shi Wang, Zhijian Ren et al. (7 authors)
World Journal of Surgical Oncology
Open Access
Published: Mar 2022
16 citations
16 citations
54 days before retraction
Ribosomal protein L5 (RPL5)/ E2F transcription factor 1 (E2F1) signaling suppresses breast cancer progression via regulating endoplasmic reticulum stress and autophagy
Xiaoping Ma, Yan Li, Bing Zhao
Bioengineered
Open Access
Published: Mar 2022
21 citations
21 citations
68 days before retraction
Integrative Analysis of the Expression Levels and Prognostic Values for NEK Family Members in Breast Cancer
Wen‐Liang Gao, Lei Niu, Weiling Chen et al. (5 authors)
Frontiers in Genetics
Open Access
Published: Mar 2022
14 citations
14 citations
68 days before retraction
Impact of Cancer Stem Cells on Therapy Resistance in Gastric Cancer
Maddalen Otaegi-Ugartemendia, Ander Matheu, Estefanía Carrasco‐García
Cancers
Open Access
Published: Mar 2022
25 citations
25 citations
73 days before retraction
LINC00152 knockdown suppresses tumorigenesis in non-small cell lung cancer via sponging miR-16-5p
Hang Hu, Chen Chen, Fugang Chen et al. (4 authors)
Journal of Thoracic Disease
Open Access
Published: Mar 2022
12 citations
12 citations
83 days before retraction
Construction and validation of a transcription factors-based prognostic signature for ovarian cancer
Qingyuan Cheng, Liman Li, Mingxia Yu
Journal of Ovarian Research
Open Access
Published: Feb 2022
10 citations
10 citations
84 days before retraction
DOK5 as a Prognostic Biomarker of Gastric Cancer Immunoinvasion: A Bioinformatics Analysis
Fengyong Luo, Zhihuai Wang, Shuai Chen et al. (7 authors)
BioMed Research International
Open Access
Published: Jan 2022
3 citations
3 citations
138 days before retraction
lncRNA NORAD promotes lung cancer progression by competitively binding to miR-28-3p with E2F2
Wenjun Mao, Shengfei Wang, Ruo Chen et al. (6 authors)
Open Medicine
Open Access
Published: Jan 2022
5 citations
5 citations
142 days before retraction
Decreased E2F2 Expression Correlates with Poor Prognosis and Immune Infiltrates in Patients with Colorectal Cancer
Yuanyuan Shang, Yuanyuan Zhang, Jie Liu et al. (11 authors)
Journal of Cancer
Open Access
Published: Jan 2022
16 citations
16 citations
142 days before retraction
Comprehensive analysis of PPPCs family reveals the clinical significance of PPP1CA and PPP4C in breast cancer
Wenjun Xie, Ying Sun, Yu Zeng et al. (9 authors)
Bioengineered
Open Access
Published: Dec 2021
25 citations
25 citations
145 days before retraction
FDI-6 and olaparib synergistically inhibit the growth of pancreatic cancer by repressing BUB1, BRCA1 and CDC25A signaling pathways
Shiqi Wu, Shihui Huang, Qianwen Lin et al. (7 authors)
Pharmacological Research
Published: Dec 2021
17 citations
17 citations
151 days before retraction
Splicing Factor DDX23, Transcriptionally Activated by E2F1, Promotes Ovarian Cancer Progression by Regulating FOXM1
Chen Zhao, Yingwei Li, Chunping Qiu et al. (9 authors)
Frontiers in Oncology
Open Access
Published: Dec 2021
12 citations
12 citations
161 days before retraction
A Comprehensive Bioinformatic Analysis of NOTCH Pathway Involvement in Stomach Adenocarcinoma
Dongyun Xue, Dong Li, Cong Dou et al. (4 authors)
Disease Markers
Open Access
Published: Dec 2021
13 citations
13 citations
166 days before retraction
Potential Prognostic Biomarkers of OSBPL Family Genes in Patients with Pancreatic Ductal Adenocarcinoma
Cheng‐Wei Chou, Yu-Hsiu Hsieh, Su‐Chi Ku et al. (11 authors)
Biomedicines
Open Access
Published: Nov 2021
21 citations
21 citations
201 days before retraction
Prognostic Value of LHFPL Tetraspan Subfamily Member 6 (LHFPL6) in Gastric Cancer: A Study Based on Bioinformatics Analysis and Experimental Validation
Yuanjie Liu, Sheng‐Yan Yin, Shuhong Zeng et al. (7 authors)
Pharmacogenomics and Personalized Medicine
Open Access
Published: Nov 2021
8 citations
8 citations
203 days before retraction
Multiple Omics Analysis Reveals E2F5 Predict Prognostic Biomarker in Diffuse Large B-Cell Lymphoma
Jinshui Tan, Mengya Zhong, Qinwei Chen et al. (9 authors)
Research Square (Research Square)
Open Access
Published: Oct 2021
207 days before retraction
Comprehensive Analysis of the Implication of PGRMC1 in Triple-Negative Breast Cancer
Xin Xu, Xiangyan Ruan, Ying Zhang et al. (8 authors)
Frontiers in Bioengineering and Biotechnology
Open Access
Published: Oct 2021
8 citations
8 citations
213 days before retraction
Systematic study on expression and prognosis of E2Fs in human colorectal cancer
Yating Ma, Shijian Wang, Jinfeng Bao et al. (4 authors)
International Journal of Clinical Oncology
Published: Oct 2021
1 citation
1 citation
217 days before retraction
Genetic variants of cell cycle pathway genes are associated with head and neck squamous cell carcinoma in the Chinese population
Mo Chen, Wenmao Xu, Guiyang Wang et al. (10 authors)
Carcinogenesis
Published: Oct 2021
5 citations
5 citations
224 days before retraction
Analyzing mRNAsi-Related Genes Identifies Novel Prognostic Markers and Potential Drug Combination for Patients with Basal Breast Cancer
Kai Huang, Yu Wu, Yunqing Xie et al. (5 authors)
Disease Markers
Open Access
Published: Oct 2021
7 citations
7 citations
231 days before retraction
Sparse canonical correlation to identify breast cancer related genes regulated by copy number aberrations
Diptavo Dutta, Ananda Sen, Jaya M. Satagopan
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Sep 2021
263 days before retraction
Circ‐E2F3 promotes cervical cancer progression by inhibiting microRNA‐296‐5p and increasing STAT3 nuclear translocation
Xiangke Cao, Qinghua Ma, Bin Wang et al. (5 authors)
Annals of the New York Academy of Sciences
Published: Sep 2021
10 citations
10 citations
264 days before retraction
DZIP1 Expression as a Prognostic Marker in Gastric Cancer: A Bioinformatics-Based Analysis
Yuanjie Liu, Jie-pin Li, Shuhong Zeng et al. (6 authors)
Pharmacogenomics and Personalized Medicine
Open Access
Published: Sep 2021
9 citations
9 citations
264 days before retraction
Comprehensive Analysis of E2F Family Members in Human Gastric Cancer
Shengbo Li, Xiaofan Yang, Wenqing Li et al. (4 authors)
Frontiers in Oncology
Open Access
Published: Aug 2021
10 citations
10 citations
265 days before retraction
Dissecting Breast Cancer Circulating Tumor Cells Competence via Modelling Metastasis in Zebrafish
Inés Martínez-Peña, Pablo Hurtado, Nuria Carmona-Ule et al. (12 authors)
International Journal of Molecular Sciences
Open Access
Published: Aug 2021
29 citations
29 citations
269 days before retraction
Correlation analysis of RDM1 gene with immune infiltration and clinical prognosis of hepatocellular carcinoma
Chen Qiu, Zuyin Li, Wanyue Cao et al. (9 authors)
Bioscience Reports
Open Access
Published: Aug 2021
4 citations
4 citations
270 days before retraction
Prognostic Value of E2F Transcription Factor Expression in Pancreatic Adenocarcinoma
Lin Luo, Gerui Zhang, Taihua Wu et al. (4 authors)
Medical Science Monitor
Open Access
Published: Aug 2021
6 citations
6 citations
276 days before retraction
High mRNA Expression of CENPL and Its Significance in Prognosis of Hepatocellular Carcinoma Patients
Zhongyuan Cui, Lijia Xiao, Fengsui Chen et al. (7 authors)
Disease Markers
Open Access
Published: Aug 2021
11 citations
11 citations
278 days before retraction
SCAMP4 is a novel prognostic marker and correlated with the tumor progression and immune infiltration in glioma
Xinqi Ge, Ziheng Wang, Rui Jiang et al. (8 authors)
The International Journal of Biochemistry & Cell Biology
Published: Aug 2021
19 citations
19 citations
284 days before retraction
Preliminary analysis of the expression of ZBTB1 in human pancreatic carcinoma
Mingyang Cheng, Yan Zeng, Yu Sun et al. (16 authors)
Journal of Cellular and Molecular Medicine
Open Access
Published: Jul 2021
2 citations
2 citations
300 days before retraction
Quick Stats
Total Citations:
140
Years Since Retraction:
3.5 years
Open Access:
Yes
Last Checked:
Jul 24, 2025